Skip to content

Clinical characteristics, current treatment status and prognosis of Chinese patients with recurrent pericarditis: a multicenter, prospective, observational study

Clinical characteristics, current treatment status and prognosis of Chinese patients with recurrent pericarditis: a multicenter, prospective, observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099629
Enrollment
Unknown
Registered
2025-03-26
Start date
2025-04-10
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent pericarditis

Interventions

research group:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria for recurrent pericarditis; 2.Currently in an episode of recurrent pericarditis; 3.Voluntarily participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Diagnosed with recurrent pericarditis secondary to a specific etiology: including tumors, tuberculosis, bacterial etiology, radiological etiology, chest trauma, severe renal insufficiency, thyroid disease, myocarditis, acute myocardial infarction, or autoimmune disease; 2.Non-Chinese nationality; 3. In the opinion of the investigator, unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Rate of first recurrence of pericarditis ;

Secondary

MeasureTime frame
Time to first recurrence of pericarditis;First remission rate and time to first remission in pericarditis;Rate of first occurrence and time to first occurrence of other serious events (pericardial tamponade, pericardial constriction, etc.);Clinical features (demographics, pericarditis, other cardiac diseases, non-cardiac diseases, vital signs, physical examination, ancillary tests);Medications for the treatment of pericarditis;Therapeutic use of medications 1 week before the first recurrence of pericarditis symptoms (pericarditis chest pain);Risk factors for primary endpoint events;

Countries

China

Contacts

Public ContactShuyang Zhang

Peking Union Medical College Hospital

shuyangzhang103@163.com+86 139 1166 7211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026